The effects of vaginal bromocriptine and dienogest on women with adenomyosis: a clinical study
article
OA: diamond
CC0
Abstract
Abstract Objective Adenomyosis occurs when endometrial glands and stroma develop in the myometrium, leading to symptoms such as pelvic pain and heavy menstrual bleeding. Method This randomized, double-blinded, controlled trial study was conducted on patients with adenomyosis referred to the Rasul-e-Akram Hospital. Group A received vaginal bromocriptine, and group B received dienogest. Transvaginal ultrasonography (TVS), visual analog scale (VAS), and pictorial blood loss assessment chart (PBLAC) evaluation were performed at the beginning and after 3, 6, and 9 months of the study. Result The mean blood visual chart 3 and 6 months after intervention in the bromocriptine group was significantly lower than the dienogest group ( P < 0.001). The mean intensity of menstrual pain 3 months after intervention was significantly lower in the dienogest group compared to the bromocriptine group ( P < 0.001). There was a significant improvement in TVS appearance in both groups at the 6-month follow-up. Conclusion Dienogest and bromocriptine both effectively reduced pain intensity, menstrual bleeding, and sonographic characteristics in patients with adenomyosis.
My notes (saved in your browser only)
Outcome instruments
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (19)
- Adenomyosis and Abnormal Uterine Bleeding: Review of the Evidence via openalex
- Bromocriptine inhibits proliferation in the endometrium from women with adenomyosis via openalex
- Diagnosing adenomyosis: an integrated clinical and imaging approach via openalex
- Efficacy, Adverse Events, and Challenges of Dienogest in the Management of Symptomatic Adenomyosis: A Comparison with Different Hormonal Treatments via openalex
- Evaluating the safety of dienogest in women with adenomyosis: A retrospective analysis via openalex
- Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter, placebo-controlled study via openalex
- Long‐term dienogest administration in patients with symptomatic adenomyosis via openalex
- Long-term treatment of dienogest with symptomatic adenomyosis: retrospective analysis of efficacy and safety in clinical practice via openalex
- Objective measures of adenomyosis on MRI and their diagnostic accuracy—a systematic review & meta‐analysis via openalex
- Pathogenesis of uterine adenomyosis: invagination or metaplasia? via openalex
- Risk factors of heavy uterine bleeding in patients with endometriosis and adenomyosis treated with dienogest via openalex
- Sonographic classification and reporting system for diagnosing adenomyosis via openalex
- Vaginal bromocriptine for treatment of adenomyosis: Impact on magnetic resonance imaging and transvaginal ultrasound via openalex
- Vaginal bromocriptine improves pain, menstrual bleeding and quality of life in women with adenomyosis: A pilot study via openalex
- W2022534203 via openalex
- W1982357798 via openalex
- W3204011092 via openalex
- W2042374015 via openalex
- W2189824736 via openalex
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0
· commercial use OK